Lancet Study On Covishield Vaccine Protection Decline Is Misquoted: Experts
NDTV
As India reported 236 Omicron cases as till today, the government and medical experts have appealed to people to follow COVID-19 appropriate behaviour.
The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.
Speaking to ANI about the Lancet study on Covishield waning antibodies after 90 days, experts say that study has been misquoted.
Dr JA Jayala, President, IMA, said, "Most of the scientific data that is available says that vaccines provide antibodies and T cell immunity as well. It is based on certain facts. Most of the scientific data is available and the studies which have been conducted wide across the country and abroad have proved that antibody is not just stopping but it is continuing.
"But we are concerned about the T cell immunity or/and cellular immunity which is long lasting by all chances and once you are getting infected with the virus or when you are getting the passive immunity by the Covishield, definitely you will have the effect of that sustaining for a longer time. It will be preventing you and helping you to come out of the severe infection you are getting," the Indian Medical Association President said.
